Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of LCZ696 in Severe Renal Impairment
NCT01569828Phase 2Completed
- Sponsor
- Novartis
- Start
- Mar 2009
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of sacubitril + valsartan in heart failure (HF), hypertension (HTN), sponsored by Novartis. Started Mar 2009; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)hypertension (HTN)
Beyond the preview
Go deeper on NCT01569828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01569828.